Cabot Wealth Management Inc. Buys 14,491 Shares of Danaher Co. (NYSE:DHR)

Cabot Wealth Management Inc. grew its position in Danaher Co. (NYSE:DHR) by 53.5% during the 4th quarter, HoldingsChannel reports. The fund owned 41,595 shares of the conglomerate’s stock after purchasing an additional 14,491 shares during the period. Cabot Wealth Management Inc.’s holdings in Danaher were worth $9,548,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in DHR. Kentucky Retirement Systems Insurance Trust Fund grew its holdings in shares of Danaher by 11.6% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after purchasing an additional 2,202 shares during the last quarter. Fort Pitt Capital Group LLC grew its stake in Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares in the last quarter. ORG Partners LLC raised its position in Danaher by 1,212.8% during the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after purchasing an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. lifted its holdings in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after buying an additional 2,465 shares during the period. Finally, Generate Investment Management Ltd purchased a new position in shares of Danaher during the fourth quarter valued at $8,044,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.9 %

DHR opened at $209.86 on Friday. The stock has a market capitalization of $151.58 billion, a price-to-earnings ratio of 39.75, a PEG ratio of 2.66 and a beta of 0.83. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a fifty day moving average of $226.71 and a two-hundred day moving average of $246.96.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the firm earned $2.09 earnings per share. On average, research analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on DHR shares. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research note on Thursday, October 31st. Wells Fargo & Company reduced their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. The Goldman Sachs Group set a $250.00 price target on Danaher in a research note on Wednesday, January 15th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.